{
    "clinical_study": {
        "@rank": "115802", 
        "arm_group": {
            "arm_group_label": "HEMOFIX", 
            "arm_group_type": "Experimental", 
            "description": "3 grams a day"
        }, 
        "brief_summary": {
            "textblock": "Hemofix is a herbal formula based on traditional Jewish and far eastern medicine created to\n      assist in wound healing and bleeding arrest. It contains herbs such as Red Clover,\n      Liquorice, Raspberry, Ginger and more. The present study will evaluate the formula on the\n      coagulation system."
        }, 
        "brief_title": "The Effect of the Nutraceutical \"Hemofix\" on the Coagulation System", 
        "completion_date": {
            "#text": "December 2013", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Von Willebrand Disease", 
            "Menorrhagia"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Menorrhagia", 
                "Von Willebrand Diseases"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Healthy volunteers and volunteers with a  mild bleeding disorder\n\n        Exclusion Criteria:\n\n          -  people with thrombophilic  and cardiovascular complications,\n\n          -  people who  are treated with anti-coagulants,\n\n          -  women taking birth control pills\n\n          -  people with a history hypercoagulability"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "75 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "40", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "July 25, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01651468", 
            "org_study_id": "HEMOFIX- HMO-CTIL"
        }, 
        "intervention": {
            "arm_group_label": "HEMOFIX", 
            "description": "unique complex herbal mixture", 
            "intervention_name": "HEMOFIX", 
            "intervention_type": "Dietary Supplement"
        }, 
        "is_fda_regulated": "No", 
        "keyword": "mild bleeding disorder", 
        "lastchanged_date": "July 28, 2012", 
        "location": {
            "contact": {
                "email": "lhadas@hadassah.org.il", 
                "last_name": "Hadas Lemberg, PhD", 
                "phone": "00 972 2 6777572"
            }, 
            "facility": {
                "address": {
                    "city": "Jerusalem", 
                    "country": "Israel"
                }, 
                "name": "Hadassah Medical Organization"
            }, 
            "investigator": {
                "last_name": "David Varon, Prof", 
                "role": "Principal Investigator"
            }, 
            "status": "Not yet recruiting"
        }, 
        "location_countries": {
            "country": "Israel"
        }, 
        "number_of_arms": "1", 
        "official_title": "Phase 1 Study of the Nutraceutical \"Hemofix\" Safety and Effect on the Coagulation System", 
        "overall_official": {
            "affiliation": "HMO", 
            "last_name": "David Varon, Prof", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": "Israel: Ministry of Health", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 1", 
        "primary_completion_date": {
            "#text": "February 2013", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "bleeding and blood test results", 
            "safety_issue": "Yes", 
            "time_frame": "one year"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01651468"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Hadassah Medical Organization", 
            "investigator_full_name": "David Varon", 
            "investigator_title": "Director of coagulation unit", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "source": "Hadassah Medical Organization", 
        "sponsors": {
            "collaborator": [
                {
                    "agency": "HEMOFIX", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "Yocheved Grossman", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "Idan Grossman", 
                    "agency_class": "Other"
                }
            ], 
            "lead_sponsor": {
                "agency": "Hadassah Medical Organization", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "September 2012", 
        "study_design": "Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Supportive Care", 
        "study_type": "Interventional", 
        "verification_date": "July 2012"
    }
}